417 related articles for article (PubMed ID: 24677192)
1. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
[TBL] [Abstract][Full Text] [Related]
3. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
[TBL] [Abstract][Full Text] [Related]
5. Is recurrent hepatitis C worse with living donors?
Kuo A; Terrault NA
Curr Opin Organ Transplant; 2009 Jun; 14(3):240-4. PubMed ID: 19395968
[TBL] [Abstract][Full Text] [Related]
6. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
[TBL] [Abstract][Full Text] [Related]
7. Donor Risk Index for African American liver transplant recipients with hepatitis C virus.
Shores NJ; Dodge JL; Feng S; Terrault NA
Hepatology; 2013 Oct; 58(4):1263-9. PubMed ID: 23696235
[TBL] [Abstract][Full Text] [Related]
8. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
10. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
11. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
Thuluvath PJ; Yoo HY
Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
[TBL] [Abstract][Full Text] [Related]
12. Impact of living donor liver transplantation on long-term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis.
Karnam RS; Azhie A; Yang C; Rogalsky A; Chen S; Xu W; Patel K; Selzner N; Lilly L; Cattral M; Bhat M
Clin Transplant; 2023 Sep; 37(9):e15008. PubMed ID: 37143204
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
14. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
[TBL] [Abstract][Full Text] [Related]
15. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
[TBL] [Abstract][Full Text] [Related]
17. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.
Shaked A; Ghobrial RM; Merion RM; Shearon TH; Emond JC; Fair JH; Fisher RA; Kulik LM; Pruett TL; Terrault NA;
Am J Transplant; 2009 Feb; 9(2):301-8. PubMed ID: 19120082
[TBL] [Abstract][Full Text] [Related]
18. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
19. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
[TBL] [Abstract][Full Text] [Related]
20. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]